A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window

Martin Bendszus, Susanne Bonekamp, Eivind Berge, Florent Boutitie, Patrick Brouwer, Elke Gizewski, Antonin Krajina, Laurent Pierot, Gary Randall, Claus Z Simonsen, Kamil Zeleňák, Jens Fiehler, Götz Thomalla, Martin Bendszus, Susanne Bonekamp, Eivind Berge, Florent Boutitie, Patrick Brouwer, Elke Gizewski, Antonin Krajina, Laurent Pierot, Gary Randall, Claus Z Simonsen, Kamil Zeleňák, Jens Fiehler, Götz Thomalla

Abstract

Rationale: The benefit of thrombectomy in patients with intracranial large vessel occlusion of the anterior circulation has been shown in selected patients in previous randomized controlled trials, but patients with extended ischemic lesions were excluded in the majority of these trials. TENSION aims to demonstrate efficacy and safety of thrombectomy in patients with extended lesions in an extended time window (up to 12 h from onset or from last seen well).

Design: TENSION is an investigator-initiated, randomized controlled, open label, blinded endpoint, European, two-arm, postmarket study to compare the safety and effectiveness of thrombectomy as compared to best medical care alone in stroke patients with extended stroke lesions defined by an Alberta Stroke Program Early Computed Tomography Scan score of 3-5 and in an extended time window. In an adaptive design study, up to 665 patients will be randomized.

Outcomes: Primary efficacy endpoint will be clinical outcome defined by the modified Rankin Scale at 90-day poststroke. The main safety endpoint will be death and dependency (modified Rankin Scale 4-6) at 90 days. Additional effect measures include adverse events, health-related quality of life, poststroke depression, and costs utility assessment.

Discussion: TENSION may make effective treatment available for patients with severe stroke in an extended time window, thereby improving functional outcome and quality of life of thousands of stroke patients and reducing the individual, societal, and economic burden of death and disability resulting from severe stroke. TENSION is registered at ClinicalTrials.gov (ClinicalTrials.gov Identifier NCT03094715).

Keywords: Acute stroke therapy; intervention; ischemic stroke; protocols; radiology; stroke; therapy; treatment.

Figures

Figure 1.
Figure 1.
Study flow chart. AE: adverse event; ASPECTS: Alberta Stroke Program Early CT Score; CT: computed tomography; CTA: computed tomography angiography; CTP: computed tomography perfusion; DWI: diffusion-weighted imaging; EuroQol 5D; MRA: magnetic resonance angiography; MRI: magnetic resonance imaging; mRS: modified Rankin Scale; NIHSS: National Institutes of Health Stroke Scale; PHQ-4: Patient Health Questionnaire-4; PROMIS-10: Patient-Reported Outcomes Measurement Information System-10; SICH: symptomatic intracranial hemorrhage.
Figure 2.
Figure 2.
The concept of treatment response in stroke patients with extended stroke lesions. ASPECTS: Alberta Stroke Program Early CT Score.

References

    1. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11–20.
    1. Saver JL, Goyal M, Diener HC. SWIFT PRIME Investigators. Stent-retriever thrombectomy for stroke. N Engl J Med 2015; 373: 1077.
    1. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296–2306.
    1. Campbell BCV, Donnan GA, Lees KR, et al. Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol 2015; 14: 846–854.
    1. Goyal M, Demchuk AM, Hill MD. Endovascular therapy for ischemic stroke. N Engl J Med 2015; 372: 2366.
    1. Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387: 1723–1731.
    1. Desilles JP, Consoli A, Redjem H, et al. Successful reperfusion with mechanical thrombectomy is associated with reduced disability and mortality in patients with pretreatment diffusion-weighted imaging-Alberta Stroke Program early computed tomography score </=6. Stroke 2017; 48: 963–969.
    1. Fiehler J, Cognard C, Gallitelli M, et al. European Recommendations on Organisation of Interventional Care in Acute Stroke (EROICAS). Int J Stroke 2016; 11: 701–716.
    1. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018; 378: 708–718. .
    1. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378: 11–21.
    1. McMeekin P, White P, Martin AJ, Christopher IP, Flynn D, Gary AF. Estimating the number of UK stroke patients eligible for endovascular thrombectomy. Eur Stroke J 2017; 2: 319–326.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa